$RTRX Travere Therapeutics, Inc. Insider Trading Week 46/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc. in week 46/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Buy | P | 8.50 | 8,700 | 73,950 | 371,756 | 363.1 K to 371.8 K (+2.40 %) |
Nov 21 2014 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Chief Executive Off ... | Buy | P | 8.20 | 1,300 | 10,660 | 363,056 | 361.8 K to 363.1 K (+0.36 %) |
Nov 19 2014 | RTRX | Retrophin, Inc. | Golding Cornelius E | Director | Buy | P | 9.00 | 2,000 | 18,000 | 25,000 | 23 K to 25 K (+8.70 %) |
Nov 19 2014 | RTRX | Retrophin, Inc. | Plotkin Horacio | Chief Medical Offic ... | Sell | S | 9.43 | 8,333 | 78,594 | 93,867 | 102.2 K to 93.9 K (-8.15 %) |
Nov 17 2014 | RTRX | Retrophin, Inc. | VALEUR JENSEN MARGARET E | General Counsel | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Nov 17 2014 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 9.45 | 100,000 | 945,000 | 100,000 |